Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated:  12/31/1969
Urology San Antonio Research
mi
from
San Antonio, TX
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
Status: Enrolling
Updated: 12/31/1969
Urology San Antonio Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients
The Effects of Mindfulness-based Stress Reduction on the Urinary Microbiome in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Status: Enrolling
Updated:  12/31/1969
TriHealth - Cincinnati Urogynecology Associates
mi
from
Cincinnati, OH
The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients
The Effects of Mindfulness-based Stress Reduction on the Urinary Microbiome in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Status: Enrolling
Updated: 12/31/1969
TriHealth - Cincinnati Urogynecology Associates
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
Dutasteride (0.5mg) Once Daily for One Year and Tamsulosin (0.4mg) Once Daily for 3 Months, Followed by Counseling on Flex Dose Tamsulosin as Needed on Improvement of Symptoms and Outcome in Men With Moderate to Severe Symptomatic BPH
Status: Enrolling
Updated:  12/31/1969
Research Institute of Deaconess Clinic
mi
from
Evansville, IN
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
Dutasteride (0.5mg) Once Daily for One Year and Tamsulosin (0.4mg) Once Daily for 3 Months, Followed by Counseling on Flex Dose Tamsulosin as Needed on Improvement of Symptoms and Outcome in Men With Moderate to Severe Symptomatic BPH
Status: Enrolling
Updated: 12/31/1969
Research Institute of Deaconess Clinic
mi
from
Evansville, IN
Click here to add this to my saved trials
Catheter Management After Pelvic Reconstructive Surgery
Catheter Management After Pelvic Reconstructive Surgery: a Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Catheter Management After Pelvic Reconstructive Surgery
Catheter Management After Pelvic Reconstructive Surgery: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Comparing Approaches to Treat Older Adult Women's Urge Incontinence: Pilot Feasibility and Randomized Controlled Trial
Comparing Mindfulness-Based Stress Reduction With the Health Enhancement Program in the Treatment of Urinary Urge Incontinence in Older Adult Women: A Pilot Feasibility and Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Comparing Approaches to Treat Older Adult Women's Urge Incontinence: Pilot Feasibility and Randomized Controlled Trial
Comparing Mindfulness-Based Stress Reduction With the Health Enhancement Program in the Treatment of Urinary Urge Incontinence in Older Adult Women: A Pilot Feasibility and Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Physical Exercise and Bladder Training Program for Urinary Incontinence
Comparative Effectiveness of Integrated Exercise and Urge Suppression Verses Usual Care for Reducing the Risk of Falls in Women With Urgency Urinary Incontinence
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Physical Exercise and Bladder Training Program for Urinary Incontinence
Comparative Effectiveness of Integrated Exercise and Urge Suppression Verses Usual Care for Reducing the Risk of Falls in Women With Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm
Human Sperm Zona Acceptor: Environmental Effects
Status: Enrolling
Updated:  6/23/2005
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm
Human Sperm Zona Acceptor: Environmental Effects
Status: Enrolling
Updated: 6/23/2005
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm
Human Sperm Zona Acceptor: Environmental Effects
Status: Enrolling
Updated:  6/23/2005
North Shore University Hospital
mi
from
Manhasset, NY
Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm
Human Sperm Zona Acceptor: Environmental Effects
Status: Enrolling
Updated: 6/23/2005
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm
Human Sperm Zona Acceptor: Environmental Effects
Status: Enrolling
Updated:  6/23/2005
Copper Hospital and Fertility Testing Laboratory and Sperm Bank
mi
from
Philadelphia, PA
Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm
Human Sperm Zona Acceptor: Environmental Effects
Status: Enrolling
Updated: 6/23/2005
Copper Hospital and Fertility Testing Laboratory and Sperm Bank
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Charles White, MD
mi
from
Mobile, AL
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Charles White, MD
mi
from
Mobile, AL
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Douglas Young, MD
mi
from
Fair Oaks, CA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Douglas Young, MD
mi
from
Fair Oaks, CA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Rodney Anderson, MD
mi
from
Stanford, CA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Rodney Anderson, MD
mi
from
Stanford, CA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Eugene Dula, MD
mi
from
Van Nuys, CA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Eugene Dula, MD
mi
from
Van Nuys, CA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Joel Kaufman, MD
mi
from
Aurora, CO
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Joel Kaufman, MD
mi
from
Aurora, CO
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Donald Bergner, MD
mi
from
Clearwater, FL
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Donald Bergner, MD
mi
from
Clearwater, FL
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Ira Klimberg, MD
mi
from
Ocala, FL
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Ira Klimberg, MD
mi
from
Ocala, FL
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Gary Friedlander, MD
mi
from
Rockville, MD
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Gary Friedlander, MD
mi
from
Rockville, MD
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Sheldon Freedman, MD
mi
from
Las Vegas, NV
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Sheldon Freedman, MD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Edward Loizides, MD
mi
from
Bay Shore, NY
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Edward Loizides, MD
mi
from
Bay Shore, NY
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Richard Landau, MD
mi
from
Sellersville, PA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Richard Landau, MD
mi
from
Sellersville, PA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
H. Pat Hezmall, MD
mi
from
Fort Worth, TX
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
H. Pat Hezmall, MD
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Michael Godschalk, MD
mi
from
Richmond, VA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Michael Godschalk, MD
mi
from
Richmond, VA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Roger Fincher, MD
mi
from
Spokane, WA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Roger Fincher, MD
mi
from
Spokane, WA
Click here to add this to my saved trials
Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms
A Double-Blind, Randomized Study of Puncturing Versus Non-Puncturing Acupuncture for the Treatment of Interstitial Cystitis Symptoms
Status: Enrolling
Updated:  6/23/2005
University of Pennsylvania Pain Medicine Center
mi
from
Philadelphia, PA
Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms
A Double-Blind, Randomized Study of Puncturing Versus Non-Puncturing Acupuncture for the Treatment of Interstitial Cystitis Symptoms
Status: Enrolling
Updated: 6/23/2005
University of Pennsylvania Pain Medicine Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Galantamine in the Treatment of Post-Traumatic Headache
Galantamine in the Preventive Treatment of Chronic Post-Traumatic Headache
Status: Enrolling
Updated:  9/13/2005
The New England Center for Headache
mi
from
Stamford, CT
Galantamine in the Treatment of Post-Traumatic Headache
Galantamine in the Preventive Treatment of Chronic Post-Traumatic Headache
Status: Enrolling
Updated: 9/13/2005
The New England Center for Headache
mi
from
Stamford, CT
Click here to add this to my saved trials
Comparison of Body and Room Temperature Saline in Urodynamics
Comparison of Urodynamic Volume Measurements Using Room and Body Temperature Saline
Status: Enrolling
Updated:  7/20/2006
Tripler Army Medical Center
mi
from
Tamc, HI
Comparison of Body and Room Temperature Saline in Urodynamics
Comparison of Urodynamic Volume Measurements Using Room and Body Temperature Saline
Status: Enrolling
Updated: 7/20/2006
Tripler Army Medical Center
mi
from
Tamc, HI
Click here to add this to my saved trials
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Status: Enrolling
Updated:  11/27/2006
Lucile Packard Childrens Hospital
mi
from
Stanford, CA
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Status: Enrolling
Updated: 11/27/2006
Lucile Packard Childrens Hospital
mi
from
Stanford, CA
Click here to add this to my saved trials
This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.
Safety and Efficacy Study of Intradetrusor Injections of Botox® for the Treatment of Urinary Incontinence Secondary to Benign Prostatic Obstruction (BTX0621)
Status: Enrolling
Updated:  5/29/2007
Urological Sciences Research Foundation
mi
from
Culver City, CA
This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.
Safety and Efficacy Study of Intradetrusor Injections of Botox® for the Treatment of Urinary Incontinence Secondary to Benign Prostatic Obstruction (BTX0621)
Status: Enrolling
Updated: 5/29/2007
Urological Sciences Research Foundation
mi
from
Culver City, CA
Click here to add this to my saved trials
Endoscopic Third Ventriculostomy (ETV) Versus Ventriculoperitoneal Shunting (VPS) for the Surgical Management of Normal Pressure Hydrocephalus
Endoscopic Third Ventriculostomy (ETV) Versus Ventriculoperitoneal Shunting (VPS) for the Surgical Management of Normal Pressure Hydrocephalus
Status: Enrolling
Updated:  5/26/2010
Johns Hopkins Hospital
mi
from
Baltimore, MD
Endoscopic Third Ventriculostomy (ETV) Versus Ventriculoperitoneal Shunting (VPS) for the Surgical Management of Normal Pressure Hydrocephalus
Endoscopic Third Ventriculostomy (ETV) Versus Ventriculoperitoneal Shunting (VPS) for the Surgical Management of Normal Pressure Hydrocephalus
Status: Enrolling
Updated: 5/26/2010
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
Status: Enrolling
Updated:  11/16/2010
UC Irvine Women's Healthcare
mi
from
Orange, CA
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
Status: Enrolling
Updated: 11/16/2010
UC Irvine Women's Healthcare
mi
from
Orange, CA
Click here to add this to my saved trials
Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients
Day Zero Urinary Catheter Removal in General Thoracic Surgery Patients Receiving Thoracic Epidural Analgesia: Recatheterization Rates and Urinary Tract Infection Occurrences
Status: Enrolling
Updated:  3/4/2011
Memorial Hospital
mi
from
Chattanooga, TN
Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients
Day Zero Urinary Catheter Removal in General Thoracic Surgery Patients Receiving Thoracic Epidural Analgesia: Recatheterization Rates and Urinary Tract Infection Occurrences
Status: Enrolling
Updated: 3/4/2011
Memorial Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Improving Continence and Quality of Life in Prostate Cancer Patients
Improving Continence and Quality of Life in Prostate Cancer Patients
Status: Enrolling
Updated:  6/1/2011
Case Comprehensive Cancer Center (UHCMC, CCF, MetroHealth)
mi
from
Cleveland, OH
Improving Continence and Quality of Life in Prostate Cancer Patients
Improving Continence and Quality of Life in Prostate Cancer Patients
Status: Enrolling
Updated: 6/1/2011
Case Comprehensive Cancer Center (UHCMC, CCF, MetroHealth)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Status: Enrolling
Updated:  6/14/2011
Center for Motion Analysis
mi
from
Farmington, CT
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Status: Enrolling
Updated: 6/14/2011
Center for Motion Analysis
mi
from
Farmington, CT
Click here to add this to my saved trials
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Status: Enrolling
Updated:  6/14/2011
Connecticut Children's Medical Center
mi
from
Hartford, CT
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Status: Enrolling
Updated: 6/14/2011
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
POCARED Diagnostics, LTD, Field Study Protocol
POCARED Diagnostics, LTD, Field Study Protocol
Status: Enrolling
Updated:  12/6/2011
Southern California Permanente Medical Group (SCPMG) Regional Reference Laboratories
mi
from
North Hollywood, CA
POCARED Diagnostics, LTD, Field Study Protocol
POCARED Diagnostics, LTD, Field Study Protocol
Status: Enrolling
Updated: 12/6/2011
Southern California Permanente Medical Group (SCPMG) Regional Reference Laboratories
mi
from
North Hollywood, CA
Click here to add this to my saved trials
POCARED Diagnostics, LTD, Field Study Protocol
POCARED Diagnostics, LTD, Field Study Protocol
Status: Enrolling
Updated:  12/6/2011
The Mayo Clinic
mi
from
Rochester, MN
POCARED Diagnostics, LTD, Field Study Protocol
POCARED Diagnostics, LTD, Field Study Protocol
Status: Enrolling
Updated: 12/6/2011
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
POCARED Diagnostics, LTD, Field Study Protocol
POCARED Diagnostics, LTD, Field Study Protocol
Status: Enrolling
Updated:  12/6/2011
Cleveland Clinic
mi
from
Cleveland, OH
POCARED Diagnostics, LTD, Field Study Protocol
POCARED Diagnostics, LTD, Field Study Protocol
Status: Enrolling
Updated: 12/6/2011
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
POCARED Diagnostics, LTD, Field Study Protocol
POCARED Diagnostics, LTD, Field Study Protocol
Status: Enrolling
Updated:  12/6/2011
Riverside Methodist Hospital
mi
from
Columbus, OH
POCARED Diagnostics, LTD, Field Study Protocol
POCARED Diagnostics, LTD, Field Study Protocol
Status: Enrolling
Updated: 12/6/2011
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Translating Unique Learning for Incontinence Prevention
Translating Unique Learning for Incontinence Prevention for Women Over the Age of 55
Status: Enrolling
Updated:  5/14/2012
University of Michigan, School of Nursing
mi
from
Ann Arbor, MI
Translating Unique Learning for Incontinence Prevention
Translating Unique Learning for Incontinence Prevention for Women Over the Age of 55
Status: Enrolling
Updated: 5/14/2012
University of Michigan, School of Nursing
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Translating Unique Learning for Incontinence Prevention
Translating Unique Learning for Incontinence Prevention for Women Over the Age of 55
Status: Enrolling
Updated:  5/14/2012
University of Pennsylvania Department of Urology
mi
from
Philadelphia, PA
Translating Unique Learning for Incontinence Prevention
Translating Unique Learning for Incontinence Prevention for Women Over the Age of 55
Status: Enrolling
Updated: 5/14/2012
University of Pennsylvania Department of Urology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Placebo-Controlled Study of Clonidine for Fecal Incontinence.
A Placebo-Controlled Study of Clonidine for Fecal Incontinence.
Status: Enrolling
Updated:  5/23/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
A Placebo-Controlled Study of Clonidine for Fecal Incontinence.
A Placebo-Controlled Study of Clonidine for Fecal Incontinence.
Status: Enrolling
Updated: 5/23/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Host Response to Urinary Tract Infection in Women
Host Response to Urinary Tract Infection in Women
Status: Enrolling
Updated:  6/12/2012
University of Washington/Hall Health Primary Care Center
mi
from
Seattle, WA
Host Response to Urinary Tract Infection in Women
Host Response to Urinary Tract Infection in Women
Status: Enrolling
Updated: 6/12/2012
University of Washington/Hall Health Primary Care Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder
Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder
Status: Enrolling
Updated:  6/14/2012
Geriatric Continence Research Unit, NE547 Montefiore UPMC
mi
from
Pittsburgh, PA
Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder
Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder
Status: Enrolling
Updated: 6/14/2012
Geriatric Continence Research Unit, NE547 Montefiore UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated:  7/2/2012
Clinical Research Facility
mi
from
Huntsville, AL
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated: 7/2/2012
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated:  7/2/2012
Clinical Research Facility
mi
from
Anaheim, CA
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated: 7/2/2012
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated:  7/2/2012
Clinical Research Facility
mi
from
Denver, CO
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated: 7/2/2012
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated:  7/2/2012
Clinical Research Facility
mi
from
New Britain, CT
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated: 7/2/2012
Clinical Research Facility
mi
from
New Britain, CT
Click here to add this to my saved trials
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated:  7/2/2012
Clinical Research Facility
mi
from
Sarasota, FL
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated: 7/2/2012
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated:  7/2/2012
Clinical Research Facility
mi
from
Meridian, ID
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Status: Enrolling
Updated: 7/2/2012
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials